News | October 19, 2023
Evonik launches Eudracap preclinic functional oral capsule for preclinical trials
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Subscribe To Our Newsletter & Stay Updated
